Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.
Jeremy Veenstra-VanderWeele
From this contributor
Why serotonin medications may yet help children with autism
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can't we tell if these medications work similarly in children with the condition?
Why serotonin medications may yet help children with autism
How to evaluate new medications for autism
There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.
How to evaluate new medications for autism
Explore more from The Transmitter
The next unit of science: Is the scientific paper due to be replaced?
Artificial intelligence is pushing scientific publishing to the brink. For a field as sprawling as neuroscience, the crisis may also be an opportunity to finally connect findings across subfields.
The next unit of science: Is the scientific paper due to be replaced?
Artificial intelligence is pushing scientific publishing to the brink. For a field as sprawling as neuroscience, the crisis may also be an opportunity to finally connect findings across subfields.
Funding crisis in Argentina sparks new wave of protests
Two years after the country’s research funding collapsed, scientists are demonstrating against the government’s failure to restore previously cut scholarships and increase salaries as required by a 2025 law.
Funding crisis in Argentina sparks new wave of protests
Two years after the country’s research funding collapsed, scientists are demonstrating against the government’s failure to restore previously cut scholarships and increase salaries as required by a 2025 law.
‘Slightly unhinged’ federal autism meeting portends unclear research priorities
The meeting last week sparked concerns about the latest Interagency Autism Coordinating Committee’s ability to perform its core function: developing a strategy to support autism research.
‘Slightly unhinged’ federal autism meeting portends unclear research priorities
The meeting last week sparked concerns about the latest Interagency Autism Coordinating Committee’s ability to perform its core function: developing a strategy to support autism research.